Scientists from the University of California, San Francisco (CA, USA) and the University of Colorado (CO, USA), have successfully tested a drug discovered in a genetic zebrafish model of epilepsy in a small pediatric clinical trial. The study, published in the journal Brain, builds on earlier work by this research group, in which they reported that the compound clemizole decreased seizure activity in zebrafish, probably through its action on the serotonin system.
Restricted Content / Members Only
This content is available to members; it’s free to become a member. If you’re already a member, please login.